The use of vitamin D analogues specific to the VDR in human prostatic tissue has resulted in a significant shrinkage of the enlarged gland in men with benign prostatic hyperplasia (Adorini et al., 2010; Colli et al., 2006; Crescioli et al., 2004). This evidence concerns the gene VDR and benign prostatic hyperplasia.